Literature DB >> 19007248

Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis.

Bin Wang1, Rainer Malik, Erich A Nigg, Roman Körner.   

Abstract

Comprehensive phosphorylation site mapping is the central goal of phosphoproteome studies, but complete protein sequence coverage is rarely obtained using one single protease. In this study, we have evaluated the use of elastase, in comparison to trypsin, to increase phosphorylation site coverage of mitotic spindle proteins enriched from cultured human cells. We took advantage of the high mass accuracy of Orbitrap mass spectrometers and optimized the database search specificity by analyzing both elastase cleavage preferences and employing a dedicated two-step database search strategy. Through this approach, we have approximately doubled the number of detectable phosphorylation sites from elastase digested samples. Remarkably, phosphorylation sites detected by trypsin and elastase were highly complementary with an overlap of less than 10%. In total, we identified 1068 phosphorylation sites using trypsin and 467 phosphorylation sites using elastase. Approximately 30% of the phosphorylation sites were exclusively identified after digestion by elastase, demonstrating the value of this enzyme for phosphoproteome studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007248     DOI: 10.1021/ac801708p

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  31 in total

Review 1.  Peptide identification by tandem mass spectrometry with alternate fragmentation modes.

Authors:  Adrian Guthals; Nuno Bandeira
Journal:  Mol Cell Proteomics       Date:  2012-05-17       Impact factor: 5.911

2.  Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue.

Authors:  Miguel Marcilla; Adán Alpízar; Manuel Lombardía; Antonio Ramos-Fernandez; Manuel Ramos; Juan Pablo Albar
Journal:  Mol Cell Proteomics       Date:  2013-12-23       Impact factor: 5.911

3.  Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression.

Authors:  Kalyan Dulla; Henrik Daub; Renate Hornberger; Erich A Nigg; Roman Körner
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

4.  A bird's-eye view of post-translational modifications in the spliceosome and their roles in spliceosome dynamics.

Authors:  Susannah L McKay; Tracy L Johnson
Journal:  Mol Biosyst       Date:  2010-07-29

5.  Characterization of nuclear localization signals (NLSs) and function of NLSs and phosphorylation of serine residues in subcellular and subnuclear localization of transformer-2β (Tra2β).

Authors:  Shu-Jing Li; Yao Qi; Jing-Jing Zhao; Ya Li; Xiao-Yan Liu; Xian-Hua Chen; Ping Xu
Journal:  J Biol Chem       Date:  2013-02-08       Impact factor: 5.157

6.  Expanding proteome coverage with orthogonal-specificity α-lytic proteases.

Authors:  Jesse G Meyer; Sangtae Kim; David A Maltby; Majid Ghassemian; Nuno Bandeira; Elizabeth A Komives
Journal:  Mol Cell Proteomics       Date:  2014-01-14       Impact factor: 5.911

7.  Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.

Authors:  Tarin M Bigley; Justin M Reitsma; Shama P Mirza; Scott S Terhune
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins.

Authors:  Quira Zeidan; Zihao Wang; Antonio De Maio; Gerald W Hart
Journal:  Mol Biol Cell       Date:  2010-04-21       Impact factor: 4.138

Review 9.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

Review 10.  Temporal control of epigenetic centromere specification.

Authors:  Luis P Valente; Mariana C C Silva; Lars E T Jansen
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.